跳至主要内容
临床试验/ACTRN12619000136101
ACTRN12619000136101招募中未知

Investigation of the Effects of the ‘Actipatch’ Pulsed Shortwave Therapy Device in a Chronic Low Back Pain Population at an Australian Pain Management Centre on Pain, Function and Associated Issues

Royal Prince Alfred Hospital0 个研究点目标入组 128 人开始时间: 2019年1月30日最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
128

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Participant is willing and able to give informed consent for participation in the trial.
  • In the Investigator’s opinion, is able and willing to comply with all trial requirements.
  • Male or female ages 18 or above with stable chronic lower back pain
  • Females of childbearing must be on birth control or practice abstinence during the study period.
  • In the event of possible pre-existing pregnancy, women of childbearing age will be screened with a urine pregnancy test. Women of childbearing potential are defined as any female who has experienced menarche and who is not permanently sterile or postmenopausal. Postmenopausal is defined as 12 consecutive months with no menses without an alternative medical cause.
  • Greater than 3 months duration of chronic low back pain i.e. cut off period for acute pain
  • A current BPI pain rating greater than 5/10 on one of the four pain VAS scales on the BPI
  • Most of the pain in the body is present in the lower back or buttock, NOT in the lower extremities, as determined during screening by the principal investigator. The investigator will verbally ask the participant if most of the pain being experienced is in the lower back/buttock area, and rely on the response for inclusion into the study.
  • Able to complete and tolerate treatment for the study period.
  • Pain stable in one area of the low back, i.e. not variable in location
  • Medication regime stable over the last 3 months

排除标准

  • Female participant who is pregnant.
  • Subjects using personal home based electrical stimulation devices
  • Prior home use of pulsed shortwave therapy. i.e ActiPatch®
  • Scheduled elective surgery or other procedures requiring general anaesthesia during the trial.
  • Planned or scheduled variation in pain related medication (analgesic or psychoactive) regime during the course of the trial.
  • Active psychiatric disorders (e.g. participants using antipsychotic medication, with bipolar disorder or schizophrenia).
  • Subjects with other concomitant illnesses (e.g., malignancy) which, in the opinion of the investigator, would preclude successful subject participation
  • Subjects diagnosed with a history of significant mood disorder will be excluded (Note that subjects with depression or anxiety with adequate control would be acceptable). Participants would be required to be stable with their moods (EPPOC data or psychological or psychiatric evaluation can be referenced in the case of doubt)
  • Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant’s ability to participate in the trial.
  • Participants who have participated in another research trial involving an investigational product in the past 12 weeks
  • Participants who are planning to change any other variables during the study period likely to affect their pain or function e.g. commencement of an exercise class; ceasing allied health treatment

研究者

相似试验